Comment on: Knop et al. (2007) Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56:1951-1959

Diabetes. 2008 Jan;57(1):e1; author reply e2-3. doi: 10.2337/db07-1470.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Area Under Curve
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Glucagon-Like Peptide 1 / blood*
  • Glucagon-Like Peptide 1 / pharmacokinetics
  • Humans
  • Incretins / physiology*
  • Models, Biological

Substances

  • Incretins
  • Glucagon-Like Peptide 1